Speech-Language Pathologists in Bellport, NY Accepting Medicare

7 Speech-Language Pathologists found. Showing 1 - 7

Cathy Jean Ekstrom Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 352 Martha Ave, Bellport, NY 11713 Phone: 631-276-6703

Annamaria C Grigoli Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 62 Bieselin Rd, Bellport, NY 11713 Phone: 646-773-1321

Monica Chosak Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 353 Martha Ave, Bellport, NY 11713 Phone: 631-286-6750

Kayla Muniz Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 916 Doane Ave, Bellport, NY 11713 Phone: 631-356-8711

Stephanie Hannigan, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 38 Drake Ave, Bellport, NY 11713 Phone: 631-806-8623

Ashley Nicole Weiler, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 353 Martha Ave, Bellport, NY 11713 Phone: 631-286-6750

Mrs. Kaitlin Cooley, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 35 Kreamer St, Bellport, NY 11713 Phone: 631-730-1627

News Archive

RNC chief predicts GOP 'tsunami' in mid-term elections

Reince Priebus says the health law will tank Democratic candidates, while Republicans have made inroads with minorities and women since the 2012 presidential election.

Berg receives Drug Discovery Technology Innovation Award for agnostic approach to drug discovery

Berg, a biopharmaceutical company committed to uncovering health solutions through a data-driven, biological research approach, was recognized today with the 2013 North American Drug Discovery Technology Innovation Award at the Frost & Sullivan Growth, Innovation and Leadership Awards Gala, the annual event by the global research organization that highlights the most promising new innovative technology across sectors.

Bedfont needs public support to represent the UK in European Business Awards

Bedfont has submitted a video entry to represent the UK and now needs the help of the public to be voted the European Public Winner.

Early HIV treatment can reduce transmission risk by 96%, preliminary study results show

Preliminary results from a multicountry clinical trial, sponsored by the National Institute for Allergy and Infectious Diseases (NIAID), show that HIV-positive people who take combination antiretroviral therapy (ART) can reduce the risk of transmitting the virus to their HIV-negative partners by 96 percent, U.S. researchers announced on Thursday " in what is being hailed as a breakthrough in HIV prevention," the Los Angeles Times reports.

Read more Medical News

› Verified 7 days ago